In Brief: U.K. may consolidate AER system, New York restricts DXM sales, Actavis divests oral contraceptives, homeopathic earache products warned
This article was originally published in The Tan Sheet
Executive Summary
U.K. eyes consolidating AER system; NY restricts DXM sales; Actavis divests oral contraceptives; ScriptPro simplifies NPLEx; firms warned for homeopathic earache products; tainted supplement recalls; CRN seeks more time for medical food comments; and vitamin K2 gains in popularity.